Хайлтын үр дүнгүүд - Egorin, Merrill J
- 49-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase -н Parise, Robert A., Shawaqfeh, Mohammad, Egorin, Merrill J., Beumer, Jan H.
Хэвлэсэн 2008текст -
2
Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient contro... -н Krown, Susan E, Fingleton, Barbara, Lee, Jeannette Y, Egorin, Merrill J, Koon, Henry B
Хэвлэсэн 2010текст -
3
Embryonic Stem Cells Lacking the Epigenetic Regulator Cfp1 are Hypersensitive to DNA-Damaging Agents and Exhibit Decreased Ape1/Ref-1 Protein Expression and Endonuclease Activity -н Tate, Courtney M., Fishel, Melissa L., Holleran, Julianne L., Egorin, Merrill J., Skalnik, David G.
Хэвлэсэн 2009текст -
4
-
5
A High-Performance Liquid Chromatography-Mass Spectrometry Assay for Quantitation of the Tyrosine Kinase Inhibitor Nilotinib in Human Plasma and Serum -н Parise, Robert A., Egorin, Merrill J., Christner, Susan M., Shah, Dhvani D., Zhou, Wei, Beumer, Jan H.
Хэвлэсэн 2009текст -
6
Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice -н Guo, Jianxia, Parise, Robert A., Joseph, Erin, Egorin, Merrill J., Lazo, John S., Prochownik, Edward V., Eiseman, Julie L.
Хэвлэсэн 2008текст -
7
Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines -н Parise, Robert A., Anyang, Bean N., Eiseman, Julie L., Egorin, Merrill J., Covey, Joseph M., Beumer, Jan H.
Хэвлэсэн 2012текст -
8
-
9
-
10
Enhancement of Cisplatin [cis-Diammine Dichloroplatinum (II)] Cytotoxicity by O(6)-Benzylguanine Involves Endoplasmic Reticulum Stress() -н Rabik, Cara A., Fishel, Melissa L., Holleran, Julianne L., Kasza, Kristen, Kelley, Mark R., Egorin, Merrill J., Dolan, M. Eileen
Хэвлэсэн 2008текст -
11
Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) -н Parise, Robert A., Eiseman, Julie L., Clausen, Dana M., Kicielinski, Kimberly P., Hershberger, Pamela A., Egorin, Merrill J., Beumer, Jan H.
Хэвлэсэн 2015текст -
12
Liquid chromatography-tandem mass spectrometric assay for the quantitation in human plasma of the novel indenoisoquinoline topoisomerase I inhibitors, NSC 743400 and NSC 725776 -н Holleran, Julianne L., Parise, Robert A., Yellow-Duke, Archibong E., Egorin, Merrill J., Eiseman, Julie L., Covey, Joseph M., Beumer, Jan H.
Хэвлэсэн 2010текст -
13
In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization -н Clausen, Dana M., Guo, Jianxia, Parise, Robert A., Beumer, Jan H., Egorin, Merrill J., Lazo, John S., Prochownik, Edward V., Eiseman, Julie L.
Хэвлэсэн 2010текст -
14
SAFETY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE COMBINATION OF SORAFENIB AND TANESPIMYCIN -н Vaishampayan, Ulka N., Burger, Angelika M., Sausville, Edward A., Heilbrun, Lance K., Li, Jing, Horiba, Naomi, Egorin, Merrill J., Ivy, Percy, Pacey, Simon, Lorusso, Patricia M.
Хэвлэсэн 2010текст -
15
PHASE II AIDS MALIGNANCY CONSORTIUM TRIAL OF TOPICAL HALOFUGINONE IN AIDS-RELATED KAPOSI’S SARCOMA -н Koon, Henry B., Fingleton, Barbara, Lee, Jeannette Y., Geyer, Julia T., Cesarman, Ethel, Parise, Robert A., Egorin, Merrill J., Dezube, Bruce J., Aboulafia, David, Krown, Susan E.
Хэвлэсэн 2011текст -
16
Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma -н Parise, Robert A., Beumer, Jan H., Kangani, Cyrous O., Holleran, Julianne L., Eiseman, Julie L., Smith, Nicola F., Covey, Joseph M., Perrine, Susan P., Egorin, Merrill J.
Хэвлэсэн 2007текст -
17
Phase I Pharmacokinetic Study of the VEGFR Tyrosine Kinase Inhibitor Vatalanib (PTK787) plus Imatinib and Hydroxyurea for Malignant Glioma -н Reardon, David A., Egorin, Merrill J., Desjardins, Annick, Vredenburgh, James J., Beumer, Jan H., Lagattuta, Theodore F., Gururangan, Sridharan, Herndon, James E., Salvado, August J., Friedman, Henry S.
Хэвлэсэн 2009текст -
18
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib -н Egorin, Merrill J, Shah, Dhvani D, Christner, Susan M, Yerk, Mara A, Komazec, Kristin A, Appleman, Leonard R, Redner, Robert L, Miller, Brian M, Beumer, Jan H
Хэвлэсэн 2009текст -
19
Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tum... -н Ramanathan, Ramesh K., Egorin, Merrill J., Erlichman, Charles, Remick, Scot C., Ramalingam, Suresh S., Naret, Cynthia, Holleran, Julianne L., TenEyck, Cynthia J., Ivy, S. Percy, Belani, Chandra P.
Хэвлэсэн 2010текст -
20
In Vitro Circuit Stability of 5-Fluorouracil and Oxaliplatin in Support of Hyperthermic Isolated Hepatic Perfusion -н Colville, Heidi, Dzadony, Ryan, Kemp, Rebecca, Stewart, Stephen, Zeh, Herbert J., Bartlett, David L., Holleran, Julianne, Schombert, Kevin, Kosovec, Juliann E., Egorin, Merrill J., Beumer, Jan H.
Хэвлэсэн 2010текст